Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) ≠ 1931
  • (-) = Burg, S.H. van der

Refine Results

Resource Type

Availability

Creation Date

Show more

Topic

Show more

Author

Show more

Language

Search results

  • RSS Feed
(49 - 72 of 279)

Pages

A pre-existing coordinated inflammatory microenvironment is associated with complete response of vulvar high-grade squamous intraepithelial lesions to different forms of immunotherapy
Immunotherapeutic Potential of TGF-beta Inhibition and Oncolytic Viruses
Strong vaccine responses during chemotherapy are associated with prolonged cancer survival
Future challenges in cancer resistance to immunotherapy
Tumor mutational load, CD8(+) T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy
Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial
Blood-based kinase activity profiling
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy
Generation of TCR-engineered reference cell samples to control T-cell assay performance
Host genetics and tumor environment determine the functional impact of neutrophils in mouse tumor models
Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies
CD163(+)cytokine-producing cDC2 stimulate intratumoral type 1 T cell responses in HPV16-induced oropharyngeal cancer
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination
Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4
Targeting of the Cancer-Associated Fibroblast-T-Cell Axis in Solid Malignancies
Long-term HPV-specific immune response after one versus two and three doses of bivalent HPV vaccination in Dutch girls
Monalizumab: inhibiting the novel immune checkpoint NKG2A
High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status
Tissue-Specific Gene Expression during Productive Human Papillomavirus 16 Infection of Cervical, Foreskin, and Tonsil Epithelium
Loss of BAP1 Is Associated with Upregulation of the NFkB Pathway and Increased HLA Class I Expression in Uveal Melanoma
Strong CD8+lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types

Pages